Connect with us


CBD Treatment Case: Eating Disorders



Any individual that has abnormal feeding behaviors that are severe enough to lead to abnormality in appetite levels, extreme variation in meal size, powerful shifts in weight, food addiction with narrow specification, uneven meal times, and/or problems in self-image perception is said to have an eating disorder.

Understanding Eating Disorders

The most common examples of eating disorders are extreme over eating or food addiction, bulimia, and anorexia nervosa. Scientists are not completely certain how eating disorders get started. However, it would appear as though a mix of factors are involved (stress, psychological or psychiatric issues, and serious imbalances in the hormonal system are most commonly indicated).

This is why the traditional medical establishment seeks to treat eating disorders with a number of different tools, leaning heavily on both medical prescriptions and psychological care.

The psychological side of it is important to approach because, in many cases, individuals have disruptions in their normal feeding behavior due to traumas of the past that need to be resolved on some level. Issues such as deep anxieties or serious feelings of guilt can lead to eating disorders over time as well.

Derivative Impact and Treatment

Eating disorders can involve a host of derivative problems as nutrient intake can lead to malnourishment which can lead to many other serious health issues. With bulimia and anorexia, the body reacts much as it might during a period of starvation or near starvation. This can lead to malnourishment, extreme muscle loss, and problems in major systems including the cardiovascular system.

In addition, the vomiting associated with bulimia can cause major problems in the upper gastrointestinal system and the mouth given the prevalence of acids from the stomach coming into contact with tissues throughout that system. This can lead to tooth decay or tears in the esophagus.

On the flip side of the coin, extreme over eating can lead to obesity, diabetes, and other serious conditions.

There are many tools in the toolbox for the current medical establishment to treat such issues. However many have unwanted side effects and collateral consequences for the patient.

The role here is potentially obvious for cannabinoids. Many people associate THC with getting “the munchies”. One can see how this may be particularly useful for an individual suffering from bulimia or anorexia that has progressed far enough that eating is difficult and an appetite can often be hard to find.

However, THC has a host of other effects, such as psychoactivity, that make it unlikely for the medical establishment to use. This has led to popularity in research about the role that CBD may be able to play in the treatment of eating disorders given that CBD does not have the psychoactive effects associated with THC.

Receptor Targeting and Application

Simply put, the point of making a modification in the functionality of the endocannabinoid system is really all about understanding which receptors are being targeted and why. It is also important for researchers to understand the difference between an agonist and an antagonist molecule in terms of how they impact these receptors.

It’s easy to understand the difference. For example, an agonist is a molecule that basically looks and acts like another molecule altogether. However, an antagonist, by contrast, is a molecule that looks just like another molecule but blocks the effect that the original molecule was meant to have. In other words, while they are both imposters, the antagonist is there to gum up the works.

When implementing CBD hemp oil in the treatment of eating disorders, the justification on a clinical basis has only been partially supported for food addiction and over eating – which can lead to obesity.

However, CBD for eating disorders characterized by under-consumption or digestion of nutrients has been somewhat contradicted because of its appetite suppressant properties. In the case of cachexia, it has only found limited research support, and more research needs to be accomplished before recommendations may start in earnest.

Hence, in the big picture, it will be important for us to continue to push the frontier of the research around this application further, compile new data, and generate new and important conclusions. There’s rich potential here to change the game for eating disorders with the application of cannabinoids.

But it will be important to establish both the precise nature of that application as well as the research basis for widespread integration into the general treatment regime.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories